ExploreWatchlistsPricing
  1. JP-listed companies
  2. Fuji Pharma Co.,Ltd.
  3. Financials
  4. Total assets

Fuji Pharma Co.,Ltd. (4554)

Market cap
¥61.9B
P/E ratio
27.2x
Develops and manufactures specialized injectable medications for hospitals and medical distributors, focusing on hormone treatments and medical imaging contrast agents.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal assets (Million JPY)YoY (%)
Sep 30, 202593,405+3.78%
Sep 30, 202490,000+5.47%
Sep 30, 202385,332+12.97%
Sep 30, 202275,538+17.59%
Sep 30, 202164,239+3.67%
Sep 30, 202061,962+2.02%
Sep 30, 201960,737+14.35%
Sep 30, 201853,117+7.20%
Sep 30, 201749,551+2.92%
Sep 30, 201648,147+5.19%
Sep 30, 201545,773-6.64%
Sep 30, 201449,027

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat